Life Span of Silicone Gel-Filled Mammary Prostheses
- 1 December 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 100 (7) , 1723-1726
- https://doi.org/10.1097/00006534-199712000-00012
Abstract
The discussion on possible side effects of implanted silicone has resulted in a growing number of patients inquiring whether or not their mammary prostheses are intact and when failure of the prostheses is to be expected. Between November 1988 and May 1995, 182 patients had their silicone mammary prostheses replaced, repositioned, or removed one to three times. Capsular contraction, dislocation, pain paresthesia, and/or suspected rupture were common indications for surgery. To try and be able to provide an indication as to the correlation of implant age and integrity, we recorded the status of all 426 prostheses observed during secondary surgery. In this selected group of patients, approximately 50 percent of the mammary prostheses with an implant age of 7 to 10 years showed gel bleed or rupture. Applying the survival Kaplan-Meier curve, 50 percent of implants may be expected to bleed or be ruptured at the age of 15 years. Rupture was observed more frequently than gel bleed. It seems that there is no chronologic relation between gel bleed and rupture. (Plast. Reconstr. Surg. 100: 1723, 1997.)Keywords
This publication has 10 references indexed in Scilit:
- Silicone Breast Implant Bleed and RuptureAnnals of Plastic Surgery, 1996
- Town and GownAnnals of Plastic Surgery, 1995
- Analysis of Explanted Silicone ImplantsAnnals of Plastic Surgery, 1995
- Health Risks of Failed Silicone Gel Breast ImplantsPublished by Wolters Kluwer Health ,1994
- Risk of Connective-Tissue Diseases and Other Disorders after Breast ImplantationNew England Journal of Medicine, 1994
- How Safe Are Silicone Breast Implants?Southern Medical Journal, 1993
- Rupture and Aging of Silicone Gel Breast ImplantsPlastic and Reconstructive Surgery, 1993
- Treatment of systemic sclerosis with recombinant interferon‐γ. A phase I/II clinical trialArthritis & Rheumatism, 1992
- The Basis of the FDA's Decision on Breast ImplantsNew England Journal of Medicine, 1992
- Systemic Sclerosis after Augmentation Mammoplasty with Silicone ImplantsAnnals of Internal Medicine, 1989